News & Updates

Nonoperative management safe, feasible after complete response in rectal cancer
Nonoperative management safe, feasible after complete response in rectal cancer
15 Jul 2022

Patients with locally advanced rectal cancer who achieve complete response (CR) following sequential short-course radiation therapy (SCRT) and chemotherapy appear to benefit from nonoperative management (NOM) with a watch-and-wait strategy, which presents evidence for good anorectal functions, results of a study have shown.

Nonoperative management safe, feasible after complete response in rectal cancer
15 Jul 2022
Low-FODMAP diet trumps medication for IBS
Low-FODMAP diet trumps medication for IBS
11 Jul 2022 byTristan Manalac

In primary care patients with irritable bowel syndrome (IBS), keeping a diet low in fermentable oligo-, di-, and monosaccharides and polyols (FODMAP), as guided by a smartphone app, yields better symptom relief than using a spasmolytic agent, according to a recent trial.

Low-FODMAP diet trumps medication for IBS
11 Jul 2022
Poor mental health tied to worse prognosis, outcomes in IBD
Poor mental health tied to worse prognosis, outcomes in IBD
06 Jul 2022
Vedolizumab appears safe, effective in first-line treatment of ulcerative colitis in children
Vedolizumab appears safe, effective in first-line treatment of ulcerative colitis in children
06 Jul 2022

Children with ulcerative colitis seem to respond well to vedolizumab in the first-line setting, inducing remission without increasing the risk of adverse events, according to a small study.

Vedolizumab appears safe, effective in first-line treatment of ulcerative colitis in children
06 Jul 2022